A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
Titel:
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
Auteur:
Mayer, Erica L. Tayob, Nabihah Ren, Siyang Savoie, Jennifer J. Spigel, David R. Burris, Howard A. Ryan, Paula D. Harris, Lyndsay N. Winer, Eric P. Burstein, Harold J.